Prostate cancer is usually accompanied by a rise in the concentration of serum PSA, which has been used for decades as a sensitive but poorly specific biomarker, and a controversial predictor of prostate cancer mortality [2], [3]. The gene discussed is KLK3; the disease is prostate carcinoma.